PAVmed Inc (PAVMZ)
0.01
0.00 (44.93%)
At close: Mar 18, 2025, 2:49 PM
0.01
0.00%
After-hours: Mar 18, 2025, 04:00 PM EDT
44.93% (1D)
| Bid | 0.01 |
| Market Cap | 8.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.01 |
| Volume | 3,029 |
| Avg. Volume (20D) | 14,602.089 |
| Open | 0.01 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.01 - 0.01 |
| Beta | 1.19 |
About PAVMZ
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA as...
Industry Medical - Devices
Sector Healthcare
IPO Date Apr 10, 2018
Employees 107
Stock Exchange NASDAQ
Ticker Symbol PAVMZ
Website https://www.pavmed.com